Umbilical Cord and Maternal Plasma Thiol Concentrations in Normal Pregnancy
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Cysteine is the only sulfhydryl-containing amino acid in proteins and is the thiol residue in glutathione (1 ) . In addition to its importance in the storage and transport of cysteine, glutathione plays a pivotal role in detoxification by the action of glutathione S-transferases and in scavenging free (oxygen) radicals by the action of glutathione peroxidases (1 ) .
Thiol metabolism may be altered during pregnancy. In healthy pregnant women, plasma concentrations of cysteine, glutathione, and homocysteine are decreased, whereas increased homocysteine and cysteine concentrations are seen in pathologic conditions, such as preeclampsia, in which oxidative stress may play an important role (2) (3) (4) .
Thiols may have important physiological functions in fetal metabolism. Although protein and amino acid turnover in the human placenta has been studied extensively (5) (6) (7) , few data concerning fetal concentrations of thiols and placental maternal-fetal thiol interactions are currently available (8 ) . During normal pregnancy, fetal growth depends on the supply of nutrients from the mother, and a clear correlation between maternal and fetal amino acid and homocysteine concentrations has been shown (6 -8 ) . Decreased concentrations of amino acids in the umbilical artery, as compared with the umbilical vein, have been interpreted as an uptake of amino acids into fetal tissues where they may be used in protein biosynthesis or as sources of energy (5 ) . We studied fetal and maternal thiol plasma concentrations in normal pregnancies to determine reference concentrations for cysteine, homocysteine, and cysteinylglycine in arterial and venous umbilical cord plasma to gain insight into maternal-fetal thiol interactions.
Arterial and venous umbilical cord blood samples from 320 consecutive neonates were drawn in preheparinized tubes immediately after birth (cat. no. 260545; Kemper Medical) from March 1997 to January 1998 at the Department of Obstetrics/Gynecology of the 'Nij Smellinghe' Hospital. Approval for this study was granted by the Institutional Review Board of the hospital. Blood gas values were assessed on an ABL-330 analyzer (Radiometer Nederland). Samples with a pH difference between arterial and venous umbilical cord blood Ͻ0.02 pH units and samples from neonates with a gestational age Ͻ37 weeks, an umbilical artery pH Ͻ7.20, a birth weight below the 10th percentile according to Kloosterman (9 ) , or who were the offspring of women with a diastolic blood pressure Ͼ90 mmHg during gestation were excluded. Antecubital maternal venous blood of 35 women was collected in parallel with the umbilical cord samples after informed consent. Samples were taken in heparinized tubes (cat. no. 367684; Becton and Dickinson) Ͻ4 h before elective caesarian delivery or Ͻ15 min after vaginal birth. Blood was centrifuged within 10 min at 1200g for 10 min at room temperature. Plasma samples were stored at Ϫ30°C for ϳ2 years until analysis. Plasma concentrations of total cysteine (tCys), total homocysteine (tHcy), and total cysteinylglycine (tCysGly) in 195 umbilical cord (102 males and 92 females; no gender was recorded for 1 neonate) and 35 maternal samples were determined by HPLC as described previously (2 ) .
After log transformation to approach normalization, we analyzed the data by the paired t-test to assess statistical differences between maternal venous blood and arterial Clinical Chemistry 47, No. 4, 2001 umbilical cord blood values. The Spearman rank coefficient of correlation was calculated when appropriate using Astute for Microsoft Excel 5.0. P Ͻ0.05 was considered significant.
The median (central 0.95 interval) characteristics for the study group (n ϭ 195) were as follows: maternal age, 29 years (20 -41 years); gestational age, 40 weeks, 3 days (37 weeks, 3 days to 42 weeks, 3 days); maternal blood pressure, 80 mmHg, phase IV Korothoff (K4; 60 -90 mmHg); birth weight, 3510 g (2800 -4570 g); and placental weight, 695 g (500 -980 g). These characteristics were representative of the population as admitted for term deliveries in the Drachten Hospital. The maternal characteristics of the subgroup (n ϭ 35) were not different from the total study group.
In arterial umbilical cord plasma, median (central 0.95 interval) values for the following were significantly lower than in venous umbilical cord plasma: Po 2 , 17 kPa (9 -34 kPa) for arterial vs 28 kPa (16 -43 kPa) for venous (P Ͻ0.0001); HCO 3 Ϫ , 19.2 mmol/L (14.7-24.5 mmol/L) for arterial vs 20.2 mmol/L (16.7-23.0 mmol/L) for venous (P Ͻ0.0001); pH 7.27 (7.20 -7.37) for arterial vs 7.34 (7.26 -7.43) for venous (P Ͻ 0.0001); and base deficit Ϫ4.4 (Ϫ9.1 to 0.5) for arterial vs Ϫ4.0 (Ϫ8.1 to 0.5) for venous (P ϭ 0.0001). Pco 2 was significantly higher in umbilical cord blood: 52 kPa (35-64 kPa) for arterial vs 40 kPa (29 -50 kPa) for venous (P Ͻ0.0001).
Concentrations of tCys and tHcy were significantly lower in arterial compared with venous umbilical cord plasma (P ϭ 0.0002 and P ϭ 0.009, respectively; see Table  1 ), whereas concentrations of tCysGly were significantly higher in arterial compared with venous umbilical cord plasma (P ϭ 0.005).
Maternal and venous and arterial umbilical cord plasma in the subgroup of 35 cases are presented in Fig. 1 . Maternal tCys concentrations were lower than venous umbilical cord plasma (P ϭ 0.04), whereas there was a tendency for higher tCys concentrations in venous vs arterial umbilical cord plasma (P ϭ 0.06). Arterial umbilical cord tCys concentrations tended to be higher than maternal concentrations (P ϭ 0.1). Associations were found between tCys concentrations in maternal and venous umbilical cord plasma (r ϭ 0.84; P Ͻ0.0001), venous and arterial umbilical cord plasma (r ϭ 0.82; P Ͻ0.0001), and arterial umbilical cord and maternal plasma (r ϭ 0.81; P Ͻ0.0001).
tHcy showed a decreasing concentration gradient from maternal to venous and arterial umbilical cord plasma (P ϭ 0.001 and P ϭ 0.04, respectively). Significantly lower tHcy concentrations were found in arterial umbilical cord vs maternal plasma (P Ͻ0.0001). Maternal and venous umbilical cord, venous and arterial umbilical cord, and arterial umbilical cord and maternal plasma concentrations of tHcy were correlated (r ϭ 0.83, P Ͻ0.0001; r ϭ 0.82, P Ͻ0.0001; and r ϭ 0.79, P Ͻ0.0001, respectively). No associations were found between maternal, arterial, and venous umbilical cord tHcy concentrations and neonatal weight (r ϭ 0.07, P ϭ 0.9; r ϭ 0.12, P ϭ 0.1; and r ϭ 0.0076, P ϭ 0.9, respectively).
No differences were found between maternal and umbilical venous or arterial tCysGly concentrations, whereas an association was found between arterial and venous cord tCysGly concentrations (r ϭ 0.59; P Ͻ0.001).
The samples analyzed in this study were from uncomplicated pregnancies, and consequently the neonatal thiol values can be used as reference values.
Concentrations of tCys and tHcy are lower in arterial vs venous umbilical cord plasma, indicating uptake of both thiols into the fetal circulation, where they may be used in the biosynthesis of glutathione and proteins. tHcy may pass the maternal-fetal barrier driven by a concentration gradient. In contrast, tCys is transported from mother to fetus against a gradient, probably by active transport. tCys must be taken up by the fetus in this way because tHcy cannot be converted to tCys by the fetus because of an absence in the fetus of cystathionine-␤-synthase, which is the enzyme that catalyzes this conversion in adults (10 ) .
Maternal thiol concentrations are comparable to those we reported previously in a study group on increased nonpregnant vs normal pregnant plasma thiol values, most probably because of an increased plasma volume in normal pregnancy (2 ) . Although the median maternal tHcy concentrations seemed higher compared with our previous findings (2 ), no statistical difference was found (P ϭ 0.45). Our tHcy values are higher than those found previously in a Northern American population (8, 11 ) , which may be explained by a higher intake of folate and B vitamins in the American population, as discussed by den Heyer et al. (12 ) . In conclusion, tCys, which is an essential amino acid in the human fetus, may be actively transported in the placenta from the maternal to the fetal circulation where it is used in biosynthesis. Similarly, the fetus may extract tHcy from the maternal circulation. With an incidence of 1 in 6600 newborns, phenylketonuria (PKU) is among the most common inborn errors of metabolism. PKU is caused by a deficiency of hepatic phenylalanine hydroxylase (1 ) . The increase in the blood Phe concentration leads to permanent structural damage of the central nervous system as a result of disturbed myelination and neurotransmitter deficiency (2 ) . If plasma Phe concentrations are normalized by a lowprotein diet with supplementation of essential amino acids before 3 weeks of age, irreversible mental retardation is prevented (2 ) . Still, strict metabolic control is mandatory throughout childhood (2 ) and perhaps into adult life (3 ). This is achieved by regular measurement of blood Phe and Tyr concentrations. Tyr is monitored because Phe hydroxylase deficiency renders it an essential amino acid in PKU. Recommendations for the duration and intensity of dietary control are not uniform (2 ); likewise, there is some variation in the local practices of PKU monitoring. The current guidelines of the German "Arbeitsgemeinschaft fü r Pädiatrische Stoffwechselerkrankungen" (The German Working Group for Metabolic Diseases) set a target range for Phe concentrations of 40 -250 mol/L, at least until age 10 (Յ900 mol/L is acceptable during adolescence) (4 ). These recommendations were based on data from samples that were analyzed immediately after sampling (Udo Wendel, University Children's Hospital, Dü sseldorf, Germany, personal communication). Pregnant women with even mild hyperphenylalaninemia also require strict dietary control of Phe concentrations to prevent PKU-induced fetopathy (1 ) .
Effect of Storage on
To ensure optimal metabolic control, patients are monitored in specialized clinics where dietary Phe intake recommendations are adjusted according to weekly to monthly Phe and Tyr measurements. To reduce the inconvenience of regular outpatient visits, most German metabolic centers (like centers in other countries) have established methods that allow patients to have capillary samples collected at home and mailed to the laboratory as whole blood (5 ) . Postal transfer of whole-blood samples takes 24 -48 h. Storage of whole blood for 6 h at 20°C has been shown not to significantly affect the recovery of Phe and Tyr (6 ) . To our knowledge, a delay of 48 h until sample preparation, which is introduced by the mailing process, has not been formally evaluated. We therefore studied the effect of delayed sample preparation on Phe and Tyr serum concentrations from whole blood.
Forty-nine blood samples from 35 PKU patients (11.9 Ϯ 10.1 years of age) were obtained by venipuncture during routine monitoring at the metabolic unit of Bonn University Children's Hospital. Blood was collected into tubes that contained bead-activating coagulation (Serum Monovette; Sarstedt). After informed consent, Phe and Tyr were measured immediately in one aliquot (Phe early , Tyr early ), whereas the second aliquot was stored as whole blood at room temperature for 48 h until amino acid analysis (Phe late , Tyr late ), thus simulating the mailing process.
Serum sample preparation included centrifugation for 10 min at 500g and deproteinization with 50 g/L sulfosalicylic acid (1:1 by volume). Amino acid analysis was performed by ion-exchange chromatography using a Clinical Chemistry 47, No. 4, 2001 
